Drugs / Humalog Mix 75/25
last change Jul 2014 re-read 2 minutes ago

Humalog Mix 75/25

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02212951 Comparator May → Jul 2014 type 2 diabetes mellitus Biodel Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Humalog Mix 75/25 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02212951
Route Subcutaneous Subcutaneous injection of 0.6 U/kg immediately before the start of the standardized breakfast” NCT02212951